Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on August 7, 2019

Feed last updated: July 04 2020 9:53 pm
Title FOA Number Organization Release Date Expiration Date Purpose Search Terms
NSF-NIH Interagency Initiative: Core Techniques and Technologies for Advancing Big Data Science and Engineering (BIGDATA) NOT-GM-12-109 NIGMS Mar 29 2012 N/A NSF-NIH Interagency Initiative: Core Techniques Technologies Advancing Big Data Science Engineering BIGDATA) Notice Number: NOT-GM-12-109 Key Dates Release Date:  March 29, 2012          Issued National Institute General Medical Sciences NIGMS), http://www.nigms.nih.gov/) National Cancer Institute NCI), http://www.nci.nih.gov/) National Human Genome Research Institute, http://www.nhgri.nih.gov) National Institute Biomedical Imaging Bioengineering NIBIB), http://www.nibib.nih.gov/) National Institute Drug Abuse NIDA), http://www.nida.nih.gov/) National Institute Neurological Disorders Stroke NINDS), http://www.ninds.nih.gov/) National Library Medicine NLM), http://www.nlm.nih.gov/) Purpose Institutes Centers the National Institutes Health NIH) the National Science Foundation NSF) identified Big Data a program focus.  particular, present initiative covers needs core techniques technologies advancing big data science engineering. Full details the programmatic goals application process described the NSF Program Solicitation NSF-12-499). Description:  BIGDATA seeks applications develop evaluate core technologies tools take advantage available collections large data sets accelerate progress science, biomedical research, engineering. addition, applications must also include description how project build capacity.  Also, project choose focus science engineering big data project an area national priority, this optional. small project receive NIH support to 150,000 direct funds to 3 years, while mid-scale projects receive NIH support ranging 150,000 650,000 direct funds to 5 years.  all, participating NIH Institutes committed to 2.75M FY 2012 and/or 2013.   It anticipated NIH pay 4 6 small projects 1 2 mid-scale projects through program fiscal years 2012 and/or 2013, subject availability funds.  Application submission through National Science Foundation. Following jointly conducted initial peer review these applications, likely NIH awardees be asked reformat application resubmit application NIH processing. Detailed information this program be obtained the Internet www.nsf.gov/funding/pgm_summ.jsp?pims_id=504767 Inquiries Potential applicants send inquiries NIH Program Contacts well NSF contacts named the solicitation NSF-12-499). Karin Remington PhD Director, Division Biomedical Technology, Bioinformatics, Computational Biology National Institute General Medical Sciences  (301) 451-6446 remingka@nigms.nih.gov data science, big data, computational, bioinformatics, computational biology
Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071 NOT-AG-18-053 NIA Dec 17 2018 N/A Notice Specify High-Priority Research Topic PAR-19-070 PAR-19-071 Notice Number: NOT-AG-18-053 Key Dates Release Date: December 17, 2018 Related Announcements PAR-19-070 PAR-19-071 Issued National Institute Aging NIA) Purpose Notice Information specifies high-priority topic interest PAR-19-070 Research Current Topics Alzheimer's Disease Its Related Dementias R01 Clinical Trial Optional)" PAR-19-071 ldquo;Research Current Topics Alzheimer's Disease Its Related Dementias R21 Clinical Trial Allowed)”. Note applications proposing exploratory developmental projects which are insufficient preliminary data well certain focused secondary analysis projects should consider using R21 FOA, whereas projects already sufficient preliminary data a very strong well-developed scientific premise should the R01 FOA. Major Opportunities Research Epidemiology Alzheimer's Disease Related Dementias Cognitive Resilience Background etiology Alzheimer’s disease related dementias AD/ADRD) proven be complex expected. Our existing cohort studies both AD/ADRD cognitive aging include social, behavioral, cognitive, neuroimaging, biomarker, genetic, epigenetic, other measures assessed longitudinally collected initially ever earlier the lifespan. Indeed, is becoming clear both risk protective factors include exposures experiences early mid-life, long before appearance any neuropathology notable cognitive decline. Continued progress the epidemiology both AD/ADRD cognitive resilience therefore likely require cohorts, diverse cohorts, participants, variables, more occasions measurement. Additionally, greater collaboration among diverse scientific disciplines be needed. Research Objectives high-priority topic encourages investigator-initiated research all aspects cognitive epidemiology relevant AD/ADRD cognitive resilience identifies specific areas build current efforts supported NIA new recommendations the 2018 Alzheimer’s Disease Research Summit see: https://www.nia.nih.gov/research/administration/recommendations-nih-ad-r... for information). following areas of particular interest the NIA. Augmenting existing longitudinal cohort studies National Institutes Health NIH) supports broad range population studies address questions related the trajectory Alzheimer’s disease other aging phenotypes. collection analysis new phenotypic information, including not limited new biomarkers, neuroimaging, non-traditional data modalities such that wearable sensors, broaden impact existing studies. addition genetic data existing newly collected cohorts the light existing novel phenotypes allow analyses how specific genetic variants polygenic risk scores contribute the risk or protection against AD/ADRD the trajectory cognitive performance. emerging opportunities stem the wider availability electronic health records administrative data e.g., CMS Medicare claims) the ability collect phenotypic data online lower cost. Enabling precision medicine AD/ADRD through deep molecular phenotyping precision-medicine approach see: http://www.nih.gov/precisionmedicine/) presents new opportunities understanding molecular determinants AD/ADRD risk cognitive resilience diverse populations at level the individual. Notice invites applications will enhance potential community-based cohort studies enable precision medicine AD/ADRD by, example: expanding types cross-sectional longitudinal ante- post-mortem-biospecimen data-collection needed generate multiple layers ldquo;omics” data; incorporating dense molecular endophenotyping e.g., genomic, epigenomic, proteomic, metabolomic, microbiomic); collecting nontraditional data modalities using wearable sensors mobile-health technologies; embedding biomarkers environmental exposure geocodes. large-scale multidimensional data generated the above approaches serve the basis future systems biology gene-environment studies the development a new taxonomy AD/ADRD prevention. Enhancing power multiethnic cohort studies. multi-factorial etiology heterogeneity AD/ADRD reveal itself racial ethnic differences overall AD/ADRD risk in putative risk protective factors in progression neuropathology. Although multi-ethnic cohorts be very informative, well-powered cohort studies needed identify specific risk protective factors vary between sub)populations. cohorts also benefit the addition measures may better help us identify determinants both disease risk cognitive resilience. 2015 Alzheimer’s Disease Research Summit includes recommendation establish new cohorts intense endophenotyping are sufficiently powered analyze effects gender diverse populations. Exploring trends the risk AD/ADRD their explanation via putative risk protective factors. Recent research well-characterized cohorts suggests age-specific risk AD/ADRD be declining some populations increasing others. answer the trend question clear implications public health policy. Trend data also provide potentially powerful to test whether putative risk protective factors truly causal. example, educational attainment appears be protective against AD/ADRD whereas both cardiovascular disease CVD) female sex confer additional risk. the reasons these observed patterns not yet clear. risk posed female sex status, example, reflect sex differences affecting disease process, may include differences the trajectory hormonal changes age in sex chromosome, gender differences educational attainment all these. Comparisons between cohorts differing these factors over time be informative may require sophisticated analyses meta-analyses replication plans. Collecting sequencing DNA samples well-characterized cases controls. Research conducted investigators the Alzheimer’s Disease Sequencing Project ADSP; see: https://www.niagads.org/adsp/content/home) others demonstrated value whole-genome whole-exome sequencing the detection genetic variants may modify AD risk protection. sequencing more genomes well-characterized cases controls family based cohorts large multiply-affected families accelerate gene discovery target identification efforts to accelerate progress the drug development pipeline. Well-characterized subjects diversity sample sets especially needed augment statistical power. Applicants interested this line research should aware current emerging NIH guidance respect sharing genomic data see: http://gds.nih.gov/) are expected facilitate rapid data-sharing according existing ADSP NIA policies, include providing types data the ADSP NIAGADS/dbGaP database https://www.niagads.org/adsp/). Electronic archiving cohort studies Although NIH encourages broad inclusive data-sharing large studies, electronic archiving data many longitudinal cohorts either incomplete relies data infrastructure is vulnerable research-funding lapses. current NIH Strategic Plan Data Science see: https://datascience.nih.gov/strategicplan for additional information) focuses enhancing discoverability usability data sets developing appropriate analysis tools, providing special opportunities collaboration between epidemiologists survey scientists the hand computer data scientists the other. addition a wealth information relevant cognitive epidemiology is trapped non-digitized obsolete formats, are highly relevant data sets biospecimen collections have never publicly shared well surveys where greater availability paradata metadata benefit researchers. welcome applications will more data available use the research community expeditiously possible, likewise encourage dissemination efforts enhance discoverability these data. Harmonizing complex data sets relevant AD/ADRD Although have substantial efforts NIH develop brief, reliable measures e.g., PROMIS® the NIH Toolbox®; see: https://www.nihpromis.org for information) well recommendations the of off-the-shelf phenotypic measures e.g., PhenX) large epidemiological studies, has less work creating crosswalks between measures those have historically used cohort studies. need harmonization across platforms particularly acute studies include longitudinal clinical, neuroimaging, genetic genomic, biomarker data are costly obtain. Coordination harmonization data existing cohort studies the Alzheimer’s Disease Neuroimaging Initiative ADNI; see: http://www.adni-info.org/ more), Accelerating Medicines Partnership AMP) effort AD/ADRD see: http://www.nih.gov/science/amp/alzheimers.htm), the ADSP see: https://www.niagads.org/adsp/content/home) also welcome. Harmonizing dementia assessment enhance cross-national comparisons. important harmonization to study dementia trends the risk protective factors against dementia) differ between cohorts, work needed the harmonization dementia-assessment methods could inform cross-national comparisons. requires than simple translation instruments, since even best ones not operate equivalently developing countries where literacy rates levels educational attainment much lower. recent examples where work being done the 10/66 Dementia Research Group see: https://www.alz.co.uk/1066/default.php) lower income countries more recent work done within US-based Health Retirement Study HRS; see: http://hrsonline.isr.umich.edu/). Both examples a harmonized cognitive assessment protocol HCAP) can used compare dementia prevalence higher- lower-income countries. Applications use extend approaches develop new approaches harmonize dementia assessment suitable cross-national comparisons feasible both clinical field settings encouraged. Inquiries Please direct inquiries to: Dallas W. Anderson, Ph.D. Division Neuroscience  National Institute Aging NIA) Telephone: 301-496-1494  Email: dallas.anderson@nih.gov Jonathan W. King, Ph.D. Division Behavioral Social Research  National Institute Aging NIA)  Telephone: 301-402-4156  Email: kingjo@nia.nih.gov data science
Notice to Extend the Expiration Date of PAR-16-204 "NLM Career Development Award in Biomedical Informatics and Data Science (K01)" and Disco NOT-LM-19-004 NLM Apr 15 2019 N/A Notice Extend Expiration Date PAR-16-204 NLM Career Development Award Biomedical Informatics Data Science K01)" Discontinue FOA Notice Number: NOT-LM-19-004 Key Dates Release Date: April 15, 2019 Related Announcements PAR-16-204 Issued National Library Medicine NLM) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-16-204 "NLM Career Development Award Biomedical Informatics Data Science K01)" be extended one receipt cycle. FOA expires on September 8, 2019. NLM does plan reissue FOA. Applicants applying the first time the June 12, 2019, September 7, 2019, due date should aware they not an opportunity resubmit a successor FOA. FOA been modified follows: Key Dates: Currently reads: Expiration Date May 8, 2019 Modified read: Expiration Date September 8, 2019 other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Hua-Chuan Sim, MD National Library Medicine NLM) Telephone: 301-594-4882 Email: simh@mail.nih.gov Jane Ye, PhD National Library Medicine NLM) Telephone: 301-594-4882 Email: yej@mail.nih.gov Alan Vanbiervliet, PhD National Library Medicine NLM) Telephone: 301-594-4882 Email: alan.vanbiervliet@nih.gov data science, informatics
Notice to Add AIDS Application Due Dates to RFA-LM-16-002 BD2K Predoctoral Training in Biomedical Big Data Science (T32) NOT-LM-16-005 NLM May 24 2016 N/A Notice Add AIDS Application Due Dates RFA-LM-16-002 BD2K Predoctoral Training Biomedical Big Data Science T32)” Notice Number: NOT-LM-16-005 Key Dates Release Date: 24, 2016 Related Announcements RFA-LM-16-002    Issued National Library Medicine NLM) Purpose purpose this Notice add AIDS application due dates RFA-LM-16-002 ldquo;BD2K Predoctoral Training Biomedical Big Data  Science T32)”.  Part 1. Key Dates Current Language: Application Due Date(s) July 25, 2016, 5:00 PM local time applicant organization. types non-AIDS applications allowed this funding opportunity announcement due this date. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. New Language: Application Due Date(s) July 25, 2016, 5:00 PM local time applicant organization. types applications allowed this funding opportunity announcement due this date. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) July 25, 2016, 5:00 PM local time applicant organization. types applications allowed this funding opportunity announcement due this date. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. other aspects the funding opportunity announcement remain same. Inquiries Please direct inquiries to: Jane Ye, PhD National Library Medicine NLM) Telephone: 301-594-4882 Email: bd2k_training@mail.nih.gov   data science, big data
Notice of Updates to the IMAG Multiscale Modeling Initiative (PAR-15-085) NOT-EB-16-011 NIBIB Dec 22 2016 N/A Notice Updates the IMAG Multiscale Modeling Initiative PAR-15-085) Notice Number: NOT-EB-16-011 Key Dates Release Date: December 22, 2016   Related Announcements PAR-15-085 Issued National Institute Biomedical Imaging Bioengineering NIBIB) National Cancer Institute NCI) National Heart, Lung, Blood Institute NHLBI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Drug Abuse NIDA) National Center Complementary Integrative Health NCCIH) National Institute Environmental Health Sciences NIEHS) Office Behavioral Social Sciences Research OBSSR) U.S. Army Research Office ARO) - Biomathematics Department Energy DOE) - Office Science, Biological Environmental Research Program (BER) U.S. Food Drug Administration (FDA) – Office In-Vitro Diagnostics Radiological Health OIR), CDRH U.S. Food Drug Administration FDA) – Office Device Evaluation ODE), CDRH U.S. Food Drug Administration FDA) – Office Science Engineering Laboratories OSEL), nbsp;CDRH National Science Foundation NSF) - Directorate Computer amp; Information Science amp; Engineering CISE) National Science Foundation NSF) - Directorate Engineering ENG) National Science Foundation NSF) - Directorate Mathematical Physical Sciences MPS) National Aeronautics Space Administration NASA) - Human Research Program HRP) Office Naval Research ONR) - Division 311 nbsp; Purpose purpose this Notice to clarify programmatic goals specific interests the interagency funding opportunity announcement FOA) PAR-15-085, Predictive Multiscale Models Biomedical, Biological, Behavioral, Environmental Clinical Research U01).  application submission process remain same.  Notice providing additional information to: 1) express particular interest applications proposing development non-standard mathematical, statistical computational modeling methods address multiscale modeling research challenges would benefit joint interagency funding.  2) update Specific Interests the 22 participating funding components the associated Scientific/Research contacts.  1) funding components the seven funding agencies very interested jointly funding integrated research efforts incorporating research non-standard multiscale modeling methods within single project.  Applicants strongly encouraged submit applications develop multiscale models are high risk, push boundaries novel multiscale modeling methodologies. Applications should emphasize addressing multiscale modeling methodological challenges, while using domain applications testbeds addressing challenges. 2) Specific Interests section below lists updated interest statements all 22 funding components.  Below, excerpted statements the six non-NIH funding components, describing examples non-standard multiscale modeling methods: ARO:  innovative modeling methods, especially traditionally quot;pure" areas mathematics such topology, differential geometry, algebra DOE:  new methods characterizing imaging molecular systems, to synthesize redesign biology processes FDA:  models predict whether proposed medical product design function properly safely NASA:  overall conceptual framework organizing principle which might better understand the organism a whole responds space flight NSF:  Advances methods tools predictive modeling, simulation, analysis emergent behavior complex multiscale systems of interest, including issues verification, validation, uncertainty quantification across scales. ONR:  Basic research modeling dynamical properties networks determining causal effects influences needed networks interconnected nodes such social biological/neural networks would helpful the applicants identify agencies may interest specific research efforts within potential research proposal. Applicants strongly encouraged consult the Scientific/Research contacts based the Specific Interests the participating funding components. of 22 funding components participating this FOA involved contributing the review funding process; reserves right fund not fund those efforts regardless decisions other agencies. nbsp;For those applications are selected potential joint funding non-NIH funding components, PD/PI be requested submit same application directly interested funding agencies after review completed.  Specific Interests: following section describes updated specific interests two the 22 participating funding components this FOA. interests examples are limited these cases. Applicants strongly encouraged see full listing Specific Interests the guidelines Section I) contact funding components. U.S. Army Research Office ARO), Biomathematics Program interested basic, high-risk, high-reward research uses, develops, analyzes mechanistic multiscale mathematical models uncover fundamental relationships a wide variety biological systems. models use mathematical techniques fields traditionally used modeling, such probability, dynamical systems, partial differential equations, innovative modeling methods especially traditionally quot;pure" areas mathematics such topology, differential geometry, algebra. particular interest currently projects use mathematical modeling find commonalities mechanism between different biological systems that express underlying principles mathematical terms, well research taking advantage recent advances neuroscience newly-available experimental data gain fundamental understanding brain physiology, cognition, neurological disease through multiscale modeling. Office Naval Research ONR) Mathematical Data Science MDS) Program concerned basic research mathematics, probability statistics, signal processing, machine learning, data engineering, information theory.  program aims develop rigorous mathematical algorithmic answers questions are currently addressed using heuristics non-principled approaches. Recent advances technology led the era massive data sets are only larger, both terms sample size dimensionality the data, also complex. data be multi-modal, multi-relational gathered different sources. massive data sets (“Big Data”) introduce unique computational statistical challenges require development new theoretical principles can extend inference learning algorithms massive scales. outstanding question the MDS program addressing how balance tradeoff between computational accuracy computational resources analyzing large complex datasets.  of most challenging datasets include networks interconnected nodes such social biological/neural networks. Basic research modeling dynamical properties networks determining causal effects influences needed this area. In addition, program interested addressing challenges collaborative decision making developing crowdsourcing methods solving complex problems. application ONR should include full work the budget corresponding only tasks associated the interests the MDS program. Furthermore, is responsibility the applicants provide justification the interagency funding support. Specifically, applicant should explain why interagency support needed how the efforts are funded different agencies benefit effort is targeting MDS program. Proposers encouraged contact Program Officer discuss research interest prior the submission formal proposals. Prior Consultation Scientific/Research Staff Consultation relevant Scientific/Research staff strongly encouraged, later the Letter Intent due date. is the same the Letter Intent, should included a separate communication the Scientific/Research Contacts, Section VII.  requested the applicants, staff advise whether proposed project meets goals this FOA.  Staff not evaluate technical scientific merit the proposed project; technical scientific merit be determined during peer review using review criteria indicated this FOA. During consultation phase, the proposed project does meet programmatic needs this FOA, applicants be strongly encouraged consider Funding Opportunities.  Inquiries Please direct inquiries to: Grace Peng, Ph.D. National Institute Biomedical Imaging Bioengineering NIBIB) Telephone: 301-451-4778 Email: grace.peng@nih.gov Jennifer Couch, Ph.D. National Cancer Institute NCI) Telephone: 240-276-6210 Email: couchj@ctep.nci.nih.gov Wen Chen, Ph.D. National Center Complementary Integrative Health NCCIH) Telephone: 301-451-3989 Email: chenw@mail.nih.gov Pankaj Qasba, Ph.D. National Heart, Lung Blood Institute NHLBI) Telephone: 301-435-0050 Email: qasbap@nhlbi.nih.gov Michael J. Pazin, Ph.D. National Human Genome Research Institute NHGRI) Telephone: 301-496-7531 Email: pazinm@mail.nih.gov Coryse St. Hillaire-Clarke, Ph.D. National Institute Aging NIA) Telephone: 301-496-9350 Email: sthillaireclacn@mail.nih.gov Gregory Bloss, M.A., M.P.P. National Institute Alcohol Abuse Alcoholism NIAAA) Telephone: 301-443-3865 Email: Gregory.Bloss@nih.gov Gayle Lester, Ph.D. National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Division Musculoskeletal Diseases Telephone: 301-594-3511 Email: lester1@mail.nih.gov Hung Tseng, Ph.D. National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Division Skin Rheumatic Disease Telephone: 301-594-5032 Email: tsengh@mail.nih.gov Regina Bures, Ph.D. Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Email: buresrm@mail.nih.gov Susan Volman, Ph.D. National Institute Drug Abuse NIDA) Telephone: 301-435-1315 Email: svolman@nida.nih.gov David Balshaw, PhD National Institute Environmental Health Sciences NIEHS) Telephone: 919-541-2448 Email: balshaw@niehs.nih.gov Bill Riley, Ph.D. Office Behavioral Social Science Research OBSSR) Telephone: 301-402-1146 Email: william.riley@nih.gov Virginia B. Pasour, PhD U.S. Army Research Office ARO) Telephone: 919-549-4254 Email: virginia.b.pasour.civ@mail.mil Ramana Madupu, Ph.D. Department Energy DOE), Biological Environmental Research Telephone: 301-366-2916 Email: ramana.madupu@science.doe.gov Donna R. Lochner Food Drug Administration FDA) Telephone: 301-796-6309 Email: donna.lochner@fda.hhs.gov Mary Ann Horn, Ph.D. National Science Foundation, Directorate Mathematical Physical Sciences NSF-MPS) Telephone: 703-292-4879 Email: mhorn@nsf.gov Vipin Chaudhary, Ph.D. National Science Foundation, Directorate Computer amp; Information Science amp; Engineering NSF-CISE) Telephone: 703-292-2254 Email: vipchaud@nsf.gov Michele Grimm, Ph.D. National Science Foundation, Directorate Engineering NSF-ENG) Telephone: 703-292-4641 Email: mgrimm@nsf.gov Pedja Neskovic, Ph.D. Office Naval Research ONR) Telephone: 703-696-4304 Email: predrag.neskovic@navy.mil Jennifer Fogarty, Ph.D. National Aeronautics Space Administration NASA) Email: jennifer.fogarty-1@nasa.gov data science, big data, computational, machine learning, neural networks, statistics
Notice of the Office of Strategic Coordination (Common Fund) Participation in RFA-ES-16-003 "BD2K Mentored Career Development Award in Biomedical NOT-RM-16-024 Roadmap May 17 2016 N/A Notice the Office Strategic Coordination Common Fund) Participation RFA-ES-16-003 BD2K Mentored Career Development Award Biomedical Big Data Science Intramural Investigators K22)" Notice Number: NOT-RM-16-024 Key Dates Release Date: 17, 2016 Related Announcements RFA-ES-16-003   Issued Office Strategic Coordination Common Fund) Purpose purpose this Notice to inform potential applicants the Office Strategic Coordination Common Fund) participating, effective immediately, the following Funding Opportunity Announcement FOA): RFA-ES-16-003 quot;BD2K Mentored Career Development Award Biomedical Big Data Science Intramural Investigators K22)" RFA-ES-16-003 updated, accordingly, reflect Common Fund's participation this FOA. are changes the Funds Available Anticipated Number Awards due the funding structure this BD2K FOA. Part I. Overview Information Components Participating Organizations National Institute Environmental Health Sciences NIEHS) National Cancer Institute NCI) National Eye Institute NEI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute Mental Health NIMH) National Library Medicine NLM) National Center Complementary Integrative Health NCCIH) National Center Advancing Translational Sciences NCATS) Division Program Coordination, Planning Strategic Initiatives, Office Disease Prevention ODP) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Office Behavioral Social Sciences Research OBSSR) Office Research Women’s Health ORWH) Office Strategic Coordination Common Fund) Catalog Federal Domestic Assistance CFDA) Number(s) 93.113; 93.398; 93.867; 93.172; 93.866; 93.273; 93.855; 93.856; 93.846; 93.865; 93.173; 93.121; 93.847; 93.279; 93.242; 93.879; 93.213; 93.350; 93.351; 93.313; 93.310 other sections this FOA remain same. Inquiries Please direct inquiries to: Leslie Derr, Ph.D. Office the Director OD) Telephone: 301 594-8174 Email: derrl@mail.nih.gov data science, big data
Notice of the National Heart, Lung, and Blood Institute (NHLBI) Participation in RFA-MD-15-005 "NIH Big Data to Knowledge (BD2K) Enhancing Divers NOT-HL-15-250 NHLBI Jan 16 2015 N/A Notice the National Heart, Lung, Blood Institute NHLBI) Participation RFA-MD-15-005 NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)" Notice Number: NOT-HL-15-250 Key Dates Release Date: January 16, 2015 Related Announcements RFA-MD-15-005 Issued National Heart, Lung, Blood Institute NHLBI) Purpose purpose this Notice to inform potential applicants the National Heart, Lung, Blood Institute NHLBI) participating, effective immediately, RFA-MD-15-005, quot;NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)". following sections RFA-MD-15-005 been updated reflect NHLBI's participation this funding opportunity announcement. Part 1.  Overview Information Components Participating Organizations National Institute Minority Health Health Disparities NIMHD) National Cancer Institute NCI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute General Medical Sciences NIGMS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Library Medicine NLM) National Center Complementary Alternative Medicine NCCAM) National Center Advancing Translational Sciences NCATS) Division Program Coordination, Planning Strategic Initiatives Office Research Infrastructure Programs ORIP) Office Behavioral Social Sciences Research OBSSR) Office Strategic Coordination Common Fund) National Heart, Lung, Blood Institute NHLBI) Catalog Federal Domestic Assistance CFDA) Numbers 93.307; nbsp;93.350;  93.213; 93.398; 93.399; 93.172; 93.866; 93.273; 93.855; 93.856; 93.846; 93.286; 93.865; 93.279; 93.173; 93.121; 93.847; 93.859; 93.242; 93.853; 93.361; 93.879; 93.351; 93.310; 93.394; 93.395; 93.396; 93.397; 93.399; 93.837; 93.838; 93.839; 93.233 Inquiries Please direct inquiries to: Weiniu Gan, Ph.D. National Heart, Lung, Blood Institute NHLBI) Telephone: 301-435-0202 Email: ganw2@mail.nih.gov nbsp; data science, big data
Notice of Technical Assistance Webinar for RFA-LM-16-001 "NLM Institutional Training Grants for Research Training in Biomedical Informatics and NOT-LM-16-003 NLM Mar 03 2016 N/A Notice Technical Assistance Webinar RFA-LM-16-001 NLM Institutional Training Grants Research Training Biomedical Informatics Data Science T15)" Notice Number: NOT-LM-16-003 Key Dates Release Date:   March 3, 2016 Related Announcements RFA-LM-16-001     Issued National Library Medicine NLM) Purpose Notice to inform scientific community a technical assistance webinar RFA-LM-16-001 quot;NLM Institutional Training Grants Research Training Biomedical Informatics Data Science T15)". NLM hold pre-application webinar Wednesday, March 23, 2016 2:00 pm EDT provide opportunity NLM staff explain goals RFA-LM-16-001, quot;NLM Institutional Training Grants Research Training Biomedical Informatics Data Science", to answer questions interested parties. prospective applicants invited participate. session provide brief overview the funding announcement, followed responses questions received advance. Topics include program goals, budget factors, review criteria timing awards.  Prospective applicants encouraged submit questions the FOA nlmepinfo@mail.nih.gov advance the event. questions, please enter quot;Question NLM Training" the subject line your message.  full funding opportunity announcement available http://grants.nih.gov/grants/guide/rfa-files/RFA-LM-16-001.html .  Details a web link join pre-application webinar be posted the NLM Extramural programs web site http://www.nlm.nih.gov/ep close business March 18, 2016. Following webinar, link the questions answers archive be posted http://www.nlm.nih.gov/ep will available until April 19, 2016. Potential applicants miss webinar encouraged use archive a source answers their questions. Any additional questions addressed the archive be directed the contact listed below. Participation this webinar, although encouraged, optional is required the submission an application RFA-LM-16-001. Inquiries Please direct inquiries to: Dr. Valerie Florance National Library Medicine NLM) Telephone: 301-496-4621 Email: florancev@mail.nih.gov data science, informatics
Notice of Special Interest: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at the Adopt NOT-OD-19-127 NIH Jul 30 2019 N/A Notice Special Interest: Small Business Innovation Research SBIR) Small Business Technology Transfer STTR) Applications Directed the Adoption the Fast Healthcare Interoperability Resources FHIR®) Standard Notice Number: NOT-OD-19-127 Key Dates Release Date: July 30, 2019 First Available Due Date: September 5, 2019 Expiration Date:April 7, 2020 Related Announcements PA-19-270 PHS 2019-02 Omnibus Solicitation the NIH Small Business Technology Transfer Grant Applications Parent STTR R41/R42] Clinical Trial Allowed) PA-19-271 PHS 2019-02 Omnibus Solicitation the NIH Small Business Technology Transfer Grant Applications Parent STTR R41/R42] Clinical Trial Required) PA-19-272 PHS 2019-02 Omnibus Solicitation the NIH, CDC, FDA Small Business Innovation Research Grant Applications Parent SBIR R43/R44] Clinical Trial Allowed) PA-19-273 PHS 2019-02 Omnibus Solicitation the NIH, CDC, FDA Small Business Innovation Research Grant Applications Parent SBIR R43/R44] Clinical Trial Required) PA-18-591 Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) NOT-OD-19-150 Issued OFFICE THE DIRECTOR, NATIONAL INSTITUTES HEALTH OD) National Eye Institute NEI) National Heart, Lung, Blood Institute NHLBI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute General Medical Sciences NIGMS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Institute Minority Health Health Disparities NIMHD) National Library Medicine NLM) National Center Complementary Integrative Health NCCIH) National Center Advancing Translational Sciences NCATS) Purpose purpose this Notice to inform SBIR STTR applicants awardees areas special interest related the of Fast Healthcare Interoperability Resources FHIR®) standard the development health information technology health IT) products services. Health can improve health care quality outcomes enabling health care providers effectively share information apply evidence support care decisions. NIH seeking innovative health solutions, implementing FHIR standard, enable effective patient-centered care coordination, population health management, data science research support. FHIR a standardized of transmitting health data one health information system another through API. API a specified set protocols data standards establish ground rules which information system directly communicates another. Software developers seamlessly connect program another computer through FHIR API transmit electronic health data. FHIR enables exchange many different health data types such clinical information, demographics, billing claims data. special relevance, complementary specification, Substitutable Medical Applications, Reusable Technologies SMART) FHIR, enables third party applications apps) access data electronic health record EHR) systems approved purposes, including research. FHIR also specifies of specific coding systems required interoperability health data. Several Federal health agencies promoting use FHIR EHR systems. 21st Century Cures Act requires a health information technology developer entity allow health information…to accessed, exchanged, used without special effort through use application programming interfaces APIs)… including providing access all data elements a patient's electronic health record.”[1] To implement provision, Department Health Human Services, Office the National Coordinator Health Information Technology ONC) proposed new rule support seamless secure access, exchange, use electronic health information.[2] Specifically, proposed rule calls the health care industry adopt standardized APIs using FHIR standard share patient data. NIH issuing Notice highlight interest receiving grant administrative supplement applications focused implementation the FHIR standard health applications including, not limited to, following area(s): Integration patient- population-level data EHR systems Access and management electronic health information Development clinical decision support systems Exchange EHR data health documentation Enhancement privacy security electronic health information Inclusion common data elements CDEs) clinical terminologies improve interoperability EHR data research clinical care Support a common structure sharing clinical research data Integration EHR patient-originated data clinical research data Design monitoring clinical trial protocols Enhancement patient recruitment, enrollment, consent clinical trials Application Submission Information Submit applications this initiative using of following funding opportunity announcements FOAs) any reissues these announcement through expiration date this notice. Activity Code FOA First Available Due Date R43/R44 PA-19-272: PHS 2019-02 Omnibus Solicitation the NIH, CDC, FDA Small Business Innovation Research Grant Applications Parent SBIR R43/R44] Clinical Trial Allowed) September 5, 2019 R41/R42 PA-19-270: PHS 2019-02 Omnibus Solicitation the NIH Small Business Technology Transfer Grant Applications Parent STTR R41/R42] Clinical Trial Allowed) September 5, 2019 R43/R44 PA-19-273: PHS 2019-02 Omnibus Solicitation the NIH Small Business Innovation Research Grant Applications Parent SBIR R43/R44] Clinical Trial Required) September 5, 2019 R41/R42 PA-19-271: PHS 2019-02 Omnibus Solicitation the NIH Small Business Technology Transfer Grant Applications Parent STTR R41/R42] Clinical Trial Required) September 5, 2019 R41/R42 R43/R44 PA-18-591: Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) September 5, 2019 Competing grant applications submitted response PA-19-270, PA-19-271, PA-19-272, PA-19-273: Applications be submitted due dates or after September 5, 2019 subsequent receipt dates through April 7, 2020. instructions the SF424 R&R) Application Guide and funding opportunity announcement used submission must followed, the following additions: funding consideration, applicants must include NOT-OD-19-127” without quotation marks) the Agency Routing Identifier field box 4B) the SF424 R&R form. Applications without information box 4B not considered this initiative. Applications nonresponsive the terms this notice the FOA used submission be withdrawn Non-competing administrative supplement applications submitted response PA-18-591: Applications be submitted September 5, 2019 through expiration date this notice, April 7, 2020. instructions the SF424 R&R) Application Guide and PA-18-591 must followed, the following additions: Applications due 5:00 PM local time applicant organization. process Streamlined Submissions using eRA Commons cannot used this initiative. funding consideration, applicants must include NOT-OD-19-127” without quotation marks) the Agency Routing Identifier field box 4B) the SF424 R&R form. Applications without information box 4B not considered this initiative. Applicants strongly encouraged notify program contact the Institute supporting parent award a request been submitted response this FOA order facilitate efficient processing the request. 1] Section 4002(D)(iv) the 21st Century Cures Act (P.L. 114 – 255) 2] https://www.federalregister.gov/documents/2019/03/04/2019-02224/21st-cen... Inquiries Please direct inquiries to: Scientific/Research, Peer Review, Financial/Grants Management contacts Section VII the listed funding opportunity announcements. data science, data integration, common data, data standards
Notice of Special Interest: Notice of Availability of Administrative Supplements for Short-term Research Career Enhancement in Genomics for Experience NOT-HG-19-025 NHGRI Oct 21 2019 N/A Notice Special Interest: Notice Availability Administrative Supplements Short-term Research Career Enhancement Genomics Experienced Investigators Notice Number: NOT-HG-19-025 Key Dates Release Date: October 21, 2019 First Available Due Date: October 21, 2019 Expiration Date: May 16, 2020 Related Announcements PA-18-591 Administrative Supplements Existing NIH Grants Cooperative Agreements Admin Supp) Issued National Human Genome Research Institute NHGRI) Purpose Notice encourages eligible National Human Genome Research Institute NHGRI) awardees grants cooperative agreements apply administrative supplements provide short-term research career enhancement genomics experienced investigators. administrative supplement provide additional funds current awardees enable investigator join awardee’s research team obtain experience directly related the scope the awardee’s project. the purposes this Notice, term ldquo;genomics” encompasses issues activities these three areas interest NHGRI – genome sciences, genomic medicine genomics society. field genomics expanded greatly over past decades it permeates much basic science clinical research. expansion occurred part via advances techniques methods, also the recognition the tools used genomics research be applied other fields. Clinical basic researchers trained than decade ago have limited opportunity acquire experience a wide range modern genomics-related topics hence benefit such exposure later their careers. Similarly, experienced genetics genomic researchers trained before genomics as integral it now benefit broadening scientific background acquiring new research capabilities modern genomics-related topics. program provide 6- 12-month hands-on supervised research experiences genomics for: 1) individuals limited no prior experience training these fields, 2) individuals genomics gain experience an aspect the field differs substantially their current work. opportunity targeted experienced academic scientists mid- late-career. Operationally, is defined at least 10 years beyond doctoral degree. will allow scientist trained a field outside genomics e.g., clinical medicine, mathematics, physics, engineering, computational science) gain supervised experience a genomics-related field, an experienced scientist obtain new knowledge skills a supervised setting an area genomics is significantly new them, such genomic data science, technology development, genomic medicine, genomics society. research experience must take place the award site, during award project period, not during any extension period. is citizenship requirement applicants. Research Strategy section should include information the goals the experience, the experience differs their previous training, how plan use experience going forward their research. Budgetary considerations: Applicants request salary support commensurate the institution’s salary structure. total salary not exceed legislatively mandated salary cap. See: https://grants.nih.gov/grants/policy/salcap_summary.htm. program-related expenses supplies, equipment, computer services, technical personnel, conference travel) be requested up 40,000 direct costs per 12 months prorated shorter periods time. Living expenses travel funds to/from research site not requested. Applicants strongly encouraged consult the Program Official the parent grant the contact listed below before submitting application confirm eligibility to obtain technical assistance. Supplement requests undergo administrative evaluation NHGRI staff. Application Submission Information Applications this initiative must submitted using following opportunity its subsequent reissued equivalent. PA-18-591 - Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) instructions the SF424 R&R) Application Guide and PA-18-591 must followed, the following additions: Application Due Date(s) – Continuous October 21, 2019 through 15, 2020   5:00 PM local time applicant organization. funding consideration, applicants must include NOT-HG-19-025 the Agency Routing Identifier field box 4B) the SF424 R&R form. Applications without information box 4B not considered this initiative. Requests be up one year support only. Individuals must commit minimum 50% effort the experience. Research Strategy section the application limited three pages. Only existing awardees NHGRI eligible apply. process Streamlined Submissions using eRA Commons cannot used this initiative. Applicants strongly encouraged notify program contact the Institute supporting parent award a request been submitted response this FOA order facilitate efficient processing the request. Inquiries Please direct inquiries to: Tina Gatlin, Ph.D. National Human Genome Research Institute Telephone: 301-480-2280 Email: gatlincl@nih.gov

Pages

XLS